Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-05-13
2008-05-13
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S051000, C549S469000, C514S470000
Reexamination Certificate
active
10579996
ABSTRACT:
The invention relates to compounds of the general formula (I) below:in which R1, R2, R3, R4, R5, R6 and X are as defined in claim1.These compounds can be used in the treatment of pathologies associated with insulin resistance syndrome.
REFERENCES:
patent: WO 99/58519 (1999-11-01), None
patent: WO 9958519 (1999-11-01), None
Pouzet et al, “Synthesis of (4-Chlorophenyl)-1-oxo-1l4-benzo[b]thien-2-yl)methanone and study of its reactivity towards sulfu- and oxygen-containing nucleophiles,” Tetrahedron (1998), vol. 54 (49), pp. 14811-14824.
J.D. Brewer et al: Annelated furans. VI. Diels-Alder addition to 3-methoxy-2-vinylbenzofurans Australian Journal of Chemistry, vol. 24, No. 9, 1971, pp. 1883-1898, XP009028907.
Kergoat Micheline
Leriche Caroline
Moinet Gerard
Coppins Janet L.
Merck Patent GmbH
Millen White Zelano & Branigan P.C.
Saeed Kamal A.
LandOfFree
Benzofurans and benzothiophenes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzofurans and benzothiophenes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzofurans and benzothiophenes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3943324